Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Laroprovstat
Sponsor:AstraZeneca AB

Contact Research Centre

Crohn's disease

Recruiting

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Tulisokibart
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:BI 690517
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Cardiac failure

Recruiting

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug

Study on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:BI 690517
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Partial seizures

Recruiting

Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

InvestigationalNo placebo

Study on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy

InvestigationalNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:BHV-7000
Sponsor:Biohaven Therapeutics Ltd.

Contact Research Centre

Other cities in Romania

The busiest research cities in the country

All 62 cities in Romania

Clinical research in Targu Mures

What the registry says about research in the country

01 Cardiovascular & Blood Disorders

Clinical research focusing on cardiovascular conditions and blood disorders, including groundbreaking trials for hypertension management and rare blood conditions.

Pulmonary Arterial Hypertension therapies
Atrial Fibrillation treatments
Paroxysmal Nocturnal Hemoglobinuria studies

Novel treatments being evaluated to improve patient outcomes in resistant hypertension and blood disorders.

02 Oncology & Hematology

Innovative research in blood cancers and lymphomas, exploring new therapeutic approaches for various forms of leukemia and lymphoma.

Chronic Myeloid Leukemia treatments
Large B-cell Lymphoma therapies
Prostate Cancer interventions

Evaluating combination therapies and targeted treatments for better cancer care outcomes.

03 Chronic Conditions

Research focused on managing chronic diseases, including innovative approaches to kidney disease, diabetes, and respiratory conditions.

Type 2 Diabetes management
Chronic Kidney Disease treatments
COPD therapeutic solutions

Studies aim to improve quality of life and disease management for patients with chronic conditions.

04 Neurological Disorders

Advanced research in neurological conditions, investigating new treatments for epilepsy and multiple sclerosis.

Multiple Sclerosis therapies
Epilepsy treatment optimization
Myasthenia Gravis management

Evaluating innovative therapeutic approaches for better neurological disease control.

Back to Romania All countries